8-K 1 a4658781.txt PSS WORLD MEDICAL 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2004 PSS WORLD MEDICAL, INC. (Exact name of Registrant as specified in its charter) Commission File Number: 0-23832 Florida 59-2280364 ------- ---------- (State or other jurisdiction (IRS Employer of incorporation or organization) Identification Number) 4345 Southpoint Blvd. Jacksonville, Florida 32216 --------------------- ----- (Address of principal executive offices) (Zip code) Registrant's telephone number (904) 332-3000 Item 5. Other Events. Attached as Exhibit 99.1 and incorporated herein by reference is a copy of a press release of PSS World Medical, Inc. (the "Company"), dated June 8, 2004, announcing that the Company's Board of Directors had authorized the repurchase of up to 5% of its outstanding common shares. Item 7. Financial Statements and Exhibits. (a) Not Applicable. (b) Not Applicable. (c) Exhibits: Exhibit Number Description ------ ------------ 99.1 Press Release dated June 8, 2004. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: June 9, 2004 PSS WORLD MEDICAL, INC. By: /s/ David M. Bronson ---------------------- Name: David M. Bronson Title: Executive Vice President and Chief Financial Officer EXHIBIT INDEX 99.1 Press Release dated June 8, 2004.